Follow
nandini acharya
nandini acharya
Post Doctoral Fellow, Harvard Medical School
Verified email at bwh.harvard.edu
Title
Cited by
Cited by
Year
Induction and transcriptional regulation of the co-inhibitory gene module in T cells
N Chihara, A Madi, T Kondo, H Zhang, N Acharya, M Singer, J Nyman, ...
Nature 558 (7710), 454-459, 2018
3872018
Tim-3 finds its place in the cancer immunotherapy landscape
N Acharya, C Sabatos-Peyton, AC Anderson
Journal for immunotherapy of cancer 8 (1), 2020
3172020
Endocannabinoid system acts as a regulator of immune homeostasis in the gut
N Acharya, S Penukonda, T Shcheglova, AT Hagymasi, S Basu, ...
Proceedings of the National Academy of Sciences 114 (19), 5005-5010, 2017
1522017
Endogenous glucocorticoid signaling regulates CD8+ T cell differentiation and development of dysfunction in the tumor microenvironment
N Acharya, A Madi, H Zhang, M Klapholz, G Escobar, S Dulberg, ...
Immunity 53 (3), 658-671. e6, 2020
1082020
Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy
CA Sabatos-Peyton, J Nevin, A Brock, JD Venable, DJ Tan, N Kassam, ...
Oncoimmunology 7 (2), e1385690, 2018
1062018
An IL-27-driven transcriptional network identifies regulators of IL-10 expression across T helper cell subsets
H Zhang, A Madi, N Yosef, N Chihara, A Awasthi, C Pot, C Lambden, ...
Cell reports 33 (8), 2020
642020
Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell function
R Tang, N Acharya, A Subramanian, V Purohit, M Tabaka, Y Hou, D He, ...
Science immunology 7 (69), eabm0631, 2022
222022
NRP1 cripples immunological memory
N Acharya, AC Anderson
Nature Immunology 21 (9), 972-973, 2020
62020
Steroid hormone regulation of immune responses in cancer
AC Anderson, N Acharya
Immunometabolism 4 (4), e00012, 2022
52022
New clones on the block
N Acharya, AC Anderson
Immunity 51 (4), 606-608, 2019
52019
Methods and compositions targeting glucocorticoid signaling for modulating immune responses
AC Anderson, M Asaf, N Acharya, VK Kuchroo, A Regev
US Patent 11,957,695, 2024
32024
Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
AC Anderson, M Asaf, N Acharya, VK Kuchroo, A Regev
US Patent 11,793,787, 2023
22023
An endogenous glucocorticoid-cytokine signaling circuit promotes CD8+ T cell dysfunction in the tumor microenvironment
N Acharya, A Madi, H Zhang, M Klapholz, E Christian, KO Dixon, G Fell, ...
bioRxiv, 799759, 2019
22019
Induced electric fields inhibit breast cancer growth and metastasis by modulating the immune tumor microenvironment
M Charan, TH Jones, DK Ahirwar, N Acharya, VV Subramaniam, ...
bioRxiv, 2024.04. 14.589256, 2024
2024
GLUCOCORTICOIDS MEDIATE FAULTY TUMOR-INFILTRATING LYMPHOCYTE FUNCTION
N Acharya, A Madi, H Zhang, M Klapholz, G Escobar, S Dulberg
CANCER DISCOVERY 10 (11), 1624-1624, 2020
2020
Tim-3 binding protein Bat3 controls dendritic cell function by regulating metabolic quiescence via ER homeostasis
R Tang, M Tabaka, C Wang, K Dixon, N Acharya, A Regev, V Kuchroo
EUROPEAN JOURNAL OF IMMUNOLOGY 49, 13-14, 2019
2019
Glucocorticoid signaling regulates CD8+ T cell responses in cancer
N Acharya, A Madi, H Zhang, M Klapholz, E Christian, KO Dixon, ...
The Journal of Immunology 202 (1_Supplement), 137.15-137.15, 2019
2019
Methods of treatment of inflammation of the gut
P Srivastava, N Acharya, S Basu
US Patent App. 15/147,022, 2017
2017
Vanilloid receptor 1 acts as a regulator of immune homeostasis in the gut (MUC8P. 731)
N Acharya
The Journal of Immunology 194 (1_Supplement), 204.11-204.11, 2015
2015
Vanilloid receptor-1 as a regulator of gut homeostasis (MUC8P. 800)
N Acharya, S Penukonda, S Basu
The Journal of Immunology 192 (1_Supplement), 198.1-198.1, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–20